MARKER THERAPEUTICS, INC.: operating_income
| Value | {"amount": -11480042, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b7421c81-eb75-4f99-af17-7d373d3c3d77
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-19-014350Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/operating-income/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b7421c81-eb75-4f99-af17-7d373d3c3d77
History
- supersedes {"amount": -11663106, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001144204-18-016734)